Nancy Thornberry's Net Worth
$1.93 Million
Who is Nancy Thornberry?
Nancy Thornberry has an estimated net worth of $1.93 Million. This is based on reported shares across multiple companies, which include Denali Therapeutics Inc., Schrodinger, Inc., and VERTEX PHARMACEUTICALS INC / MA.
SEC CIK
Nancy Thornberry's CIK is 0001797826
Past Insider Trading and Trends
2023 was Nancy Thornberry's most active year for acquiring shares with 6 total transactions. Nancy Thornberry's most active month to acquire stocks was the month of May. 2022 was Nancy Thornberry's most active year for disposing of shares, totalling 2 transactions. Nancy Thornberry's most active month to dispose stocks was the month of April. 2023 saw Nancy Thornberry paying a total of $171,072.00 for 51,601 shares, this is the most they've acquired in one year. In 2023 Nancy Thornberry cashed out on 29,700 shares for a total of $519,750.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Denali Therapeutics Inc. (DNLI) Snapshot price: $25.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +46.94% | 5.97K |
—
|
—
| 18.68K |
May 31
| |||
Form 4
| +49.62% | 4.22K |
—
|
—
| 12.71K |
Jun 1
| |||
Form 4
| +238.39% | 5.99K |
—
|
—
| 8.5K |
Jun 2
| |||
Form 4
| +33.28% | 627 |
—
|
—
| 2.51K |
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Schrodinger, Inc. (SDGR) Snapshot price: $20.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +80.00% | 5K |
—
|
—
| 11.25K |
Jun 18
| |||
Form 4
|
∞
| 6.25K |
—
|
—
| 6.25K |
Jun 15
| |||
Form 4
|
—
|
0
|
$23.26 | -$348,678.00 |
0
|
May 22
| |||
Form 4
|
—
|
0
|
$23.26 | -$116,226.00 |
0
|
Scheduled
|
Aug 11
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VERTEX PHARMACEUTICALS INC / MA (VRTX) Snapshot price: $468
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +44.10% | 501 |
—
|
—
| 1.64K |
May 1
| |||
Form 4
|
∞
| 1.14K |
—
|
—
| 1.14K |
Dec 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||